CDC vs DGRO

CDCBVictoryShares US EQ Income Enhanced Volatility Wtd ETF

DGROAiShares Core Dividend Growth ETF

In short

CDC A dividend fund with a built-in seatbelt: the index weights high-yielding US large caps by volatility instead of size, and can shift part of the portfolio into cash after deep market declines.

DGRO BlackRock's dividend-growth screen casts a wider net than most: five straight years of raises rather than ten, plus a payout-ratio cap that filters out stretched payers. About 400 US dividend raisers, large through small cap, for 0.08% a year.

Stated mandate

CDC The Fund seeks to track, before fees and expenses, a U.S. large-cap high-dividend index that uses long/cash positioning and volatility weighting. It generally invests at least 80% of assets in securities included in that index.

DGRO The fund seeks to follow an index of U.S. equities whose dividends have grown consistently.

Why people hold it

• CDC The long/cash rule is the hook. The index can move part of the portfolio to cash when the market falls hard, then rebuild equity exposure as it recovers. Rare in dividend land.
• Volatility weighting spreads roughly 100 dividend payers by how much each one swings, so the biggest names don't automatically get the biggest slots.
• Running since 2014 and pays monthly, a cadence most equity dividend funds don't offer.
• The portfolio itself is one of the sturdier builds in the dividend-screen group, and the fund sits in the upper half of that peer set overall.

• DGRO Costs 0.08% a year, a small fraction of the typical fee among US dividend-screen ETFs.
• The screen has teeth: a qualified dividend, five years of uninterrupted dividend growth, a payout ratio under 75%, and the top decile of yielders cut before the other tests run.ishares.com
• Roughly 400 names across large, mid and small caps, weighted by the dividend dollars each company pays rather than by market cap.ishares.comcib.barclays
• Tracks the Morningstar US Dividend Growth Index about as tightly as this group gets, and it's an actively traded, multi-billion-dollar fund that has run since 2014.

Worth knowing

• CDC At 0.38% it's right around the middle of dividend screens, but plain-vanilla rivals like SCHD (0.06%) and VIG (0.04%) cost a fraction. The rules aren't free.
• Thinly traded next to the mega dividend funds, so spreads can run wider and size matters when you're placing an order.
• The cash switch is reactive by design: it responds to declines that already happened rather than anticipating them.

• DGRO Chopping the highest-yielding decile is deliberate: this is built around payout growth and dividend durability, not the fattest current yield on the shelf.ishares.com
• Only dividend payers qualify, so some of the market's biggest non-paying growth companies sit outside the portfolio by rule.ishares.com
• Income arrives quarterly, not monthly, and this is plain US stock exposure: no buffer, no hedge, full equity risk.

Full CDC profile⁠

Full DGRO profile⁠